Spring Carnival. This event is perfect for the whole family and all are welcome. Activities will include spin art, balloon making, face painting, crafting and more. April 22nd is Earth Day so we will also have activities to celebrate our planet! Light lunch will be provided. Click here to register.
http://cancerpathways.org/
January 2015. HRA’s most recent syndicated study tackles the future of incentive-driven pathway adherence by asking key questions that will inform the future of this practice and outline for pharmaceutical manufacturers steps that they can take to become an active part of the conversation.
http://www.hraresearch.com/syndicated-reports/Evidence-Based-Oncology-Future-of-Incentive-Driven-Pathway-Adherence
To fulfill the current need to discuss the use of pathways and clinical treatment guidelines (referred to throughout as guidelines) in oncology and address how patient care is impacted by their use, NCCN convened the NCCN Oncology Policy Summit: Equity in Cancer Care–Pathways, Protocols, and Guidelines in Washington, DC, on Friday, May 11, 2012.
http://www.jnccn.org/content/10/Suppl_1/S-1.full
Although the pathway program initially focused on chemotherapy protocols for 3 or 4 diseases, these have expanded to cover 95% of cancer incidences and include decisions surrounding prognostic testing, imaging, radiation therapy, and supportive care.
http://www.jnccn.org/content/10/Suppl_1/S-1.full
Cancer Treatment Pathways: reviewed by oncologists. Pathways are developed using a rigorous process of evidence-based medicine. Cancer Treatment Pathways are selected from therapies recommended by national guidelines on the basis of: Clinical benefit (efficacy) Side-effects (toxicity), especially those that lead to hospitalizations or impact quality of life.
https://anthem.aimoncology.com/CancerTreatmentPathways.html
Via Oncology. Helping You Thrive. Via Oncology helps cancer centers demonstrate the value of their care to patients, referring physicians and payers. Via Oncology does this through the development and implementation of clinical pathways in collaboration with its network of cancer centers.
http://www.viaoncology.com/
Cancer Treatment Pathways: reviewed by oncologists. Pathways are developed using a rigorous process of evidence-based medicine. Standards of oncologic care evolve rapidly and keeping pace with change is vital to the health of your patients.
https://anthem.aimoncology.com/CancerTreatmentPathways.html
P4 Pathways (A Cardinal Health Company) According to the P4 Pathways Web site, P4 Healthcare’s Pathways Program partners with payers across the country to establish clinically proven, evidence-based oncology treatment protocols designed to promote the delivery of high quality, cost efficient patient care.
http://www.jnccn.org/content/10/Suppl_1/S-1.full
Oncology Pathways: Future of Incentive-Driven Adherence. HRA’s most recent syndicated study tackles the future of incentive-driven pathway adherence by asking key questions that will inform the future of this practice and outline for pharmaceutical manufacturers steps that they can take to become an active part of the conversation.
http://www.hraresearch.com/syndicated-reports/Evidence-Based-Oncology-Future-of-Incentive-Driven-Pathway-Adherence
Equity in Cancer Care: Pathways, Protocols, and Guidelines. Click here for the white paper. On Friday, May 11, 2012, the National Comprehensive Cancer Network (NCCN) convened the NCCN Oncology Policy Summit - Equity in Cancer Care: Pathways, Protocols, and Guidelines in Washington, DC at the Washington Plaza Hotel.
https://www.nccn.org/professionals/meetings/oncology_policy_program/equity.aspx
what are oncology pathways
Oncology pathways are the future of incentive-driven pathway adherence by asking key questions that will inform the future of this practice and outline for pharmaceutical manufacturers steps that they can take to become an active part of the conversation.